Tesamorelin is a synthetic growth hormone-releasing factor analog used to treat excess abdominal fat in HIV patients with lipodystrophy. It stimulates the production of growth hormone, which helps reduce visceral adipose tissue and improve lipid profiles. Tesamorelin is administered via daily subcutaneous injections and has been shown to effectively decrease abdominal fat without significant adverse effects, offering a targeted approach to managing this challenging condition.
link:http://www.tirz-peptide.com